Researchers selected an appropriate cytokine, IL-18, based on the special cytokine expression profile in severe pneumonia of mice induced by H1N1virus to prime human umbilical cord-MSCs in vitro and improved the therapeutic effect of hUC-MSCs in vivo.
[Cell Death & Disease]